| nuclear jaundice | <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy. (12 Dec 1998) |
|---|---|
| infectious jaundice | Sometimes used in referring to viral hepatitis type A. See: Weil's disease (05 Mar 2000) |
| infective jaundice | Acute onset of malaise, fever, myalgia, nausea, anorexia, abdominal pain, and icterus caused by members of the genus Leptospira. (05 Mar 2000) |
| obstructive jaundice | Jaundice resulting from obstruction to the flow of bile into the duodenum, whether intra-or extrahepatic. Synonym: mechanical jaundice. (05 Mar 2000) |
| toxaemic jaundice | <haematology> Haemolytic jaundice is a type of jaundice, where the skin takes on a yellowish hue, which occurs when red blood cells have been destroyed (by haemolysis). (09 Oct 1997) |
| jaundice | <clinical sign> Yellowing of the skin (and whites of eyes) by bilirubin, a bile pigment. Frequently because of a liver problem. (18 Nov 1997) |
| jaundice, chronic idiopathic | A familial chronic form of nonhemolytic jaundice thought to be due to a defect in the excretion of conjugated bilirubin and certain other organic anions (e.g., sulfobromophthalein) by the liver. It is characterised by the presence of a brown, coarsely granular pigment in the hepatic cells, which is pathognomonic of the condition. (12 Dec 1998) |
| jaundice of the newborn | Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system. Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice. (05 Mar 2000) |
| jaundice root | The dried rhizome of Hydrastis canadensis (family Ranunculaceae), a native of the eastern U.S.; formerly used in the treatment of chronic catarrhal states of the mucous membranes and in metrorrhagia. Synonym: golden seal, jaundice root, yellow root. Origin: Mod. L. Fr. G. Hydor (hydro-), water, + drao, to accomplish (05 Mar 2000) |
| familial nonhaemolytic nonobstructive jaundice | An inherited disorder that affects the way bilirubin in handled by the liver. Thought to be due to an inborn error of bilirubin metabolism. Symptoms include mild jaundice, weakness, fatigue, nausea and abdominal pain. (27 Sep 1997) |
| familial nonhemolytic jaundice | Mild jaundice due to increased amounts of unconjugated bilirubin in the plasma without evidence of liver damage, biliary obstruction, or haemolysis; thought to be due to an inborn error of metabolism in which the excretion of bilirubin by the liver is defective, ascribed to decreased conjugation of bilirubin as a glucuronide or impaired uptake of hepatic bilirubin. Synonym: benign familial icterus, constitutional hepatic dysfunction, Gilbert's disease, Gilbert's syndrome, Hebra's disease. (05 Mar 2000) |
| leptospiral jaundice | Jaundice associated with infection by various species of Leptospira. (05 Mar 2000) |
| adeno-associated virus | <virology> A genus of viruses in the family Parvoviridae which are all defective viruses (unable to replicate by themselves) and depend on the co-infection of their host cell by other, nondefective viruses to help them replicate. (09 Oct 1997) |
| aids-associated nephropathy | Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients. (12 Dec 1998) |
| antigens, tumour-associated, carbohydrate | Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. (12 Dec 1998) |